“I worked alongside Amrutesh at NYU Langone Health, first as a collaborator and then as a colleague. Serving as our lab’s most senior member, he spearheaded high parameter flow cytometry and AbSeq Single-cell Analysis projects. As a result, Amrutesh helped mentor me and quickly became one of my favorite coworkers. In addition, his dedication, resourcefulness, and positivity even in the face of seemingly insurmountable obstacles were nothing short of an inspiration. Therefore, I found our tenure together both rewarding and professionally engaging.”
About
Activity
-
Nature Biotech just did an excellent piece on Indapta following an in-depth interview with our CSO, Stefanie Mandl-Cashman, Ph.D. It provides an…
Nature Biotech just did an excellent piece on Indapta following an in-depth interview with our CSO, Stefanie Mandl-Cashman, Ph.D. It provides an…
Liked by Amrutesh Puranik, Ph.D.
-
The link to the webinar I gave recently on nonlinear dimensionality reduction tools (eg. t-SNE, UMAP) is in the post below. In it, I do a deep dive…
The link to the webinar I gave recently on nonlinear dimensionality reduction tools (eg. t-SNE, UMAP) is in the post below. In it, I do a deep dive…
Liked by Amrutesh Puranik, Ph.D.
-
📢 Congratulations on an amazing #immunotherapy paper just published in #Science! Thank you Abhishek D. Garg for your trust in us! We’re incredibly…
📢 Congratulations on an amazing #immunotherapy paper just published in #Science! Thank you Abhishek D. Garg for your trust in us! We’re incredibly…
Liked by Amrutesh Puranik, Ph.D.
Experience & Education
Licenses & Certifications
Publications
-
A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
Clin Cancer Res
Abstract
Purpose: We previously showed that elevated frequencies of peripheral blood CD3+CD4+CD127-GARP-CD38+CD39+ T-cells was associated with checkpoint immunotherapy resistance in metastatic melanoma patients. In the present study we sought to further investigate this population of ectoenzyme expressing T-cells (Teee). Expeirmental Design: Teee derived from the peripheral blood of metastatic melanoma patients were evaluated by bulk RNA-seq and flow cytometry. The presence of Teee in the…Abstract
Purpose: We previously showed that elevated frequencies of peripheral blood CD3+CD4+CD127-GARP-CD38+CD39+ T-cells was associated with checkpoint immunotherapy resistance in metastatic melanoma patients. In the present study we sought to further investigate this population of ectoenzyme expressing T-cells (Teee). Expeirmental Design: Teee derived from the peripheral blood of metastatic melanoma patients were evaluated by bulk RNA-seq and flow cytometry. The presence of Teee in the tumor microenviroment was assessed using publically available single-cell RNA-seq datasets of melanoma, lung, and bladder cancer along with multispectral immunofluorescent imaging of melanoma patient FFPE specimens. Suppressive function of Teee was determined by an in vitro autologous suppression assay.
Results: Teee had phenotypes associated with proliferation, apoptosis, exhaustion, and high expression of inhibitory molecules. Cells with a Teee gene signature were present in melanoma, lung cancer and bladder cancer patients' tumors. CD4+ T-cells co-expressing CD38 and CD39 in the tumor microenvironment were preferentially associated with Ki67- CD8+ T-cells. Co-culture of patient Teee with autologous T-cells resulted in decreased proliferation of target T-cells. High baseline intra-tumoral frequencies of Teee were associated with checkpoint immunotherapy resistance and poor overall survival in metastatic melanoma patients.
Conclusions: These results demonstrate that a novel population of CD4+ T-cells co-expressing CD38 and CD39 is found both in the peripheral blood and tumor of melanoma patients and is associated with checkpoint immunotherapy resistance.Other authorsSee publication -
Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy
Journal of the American Society of Nephrology
Abstract
Background
Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery stenosis (RAS) induces stenotic-kidney dysfunction and injury, but whether these arise from cellular senescenceand their temporal pattern remain unknown.
Methods
Chronic renal ischemia was induced in transgenic INK-ATTAC and…Abstract
Background
Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery stenosis (RAS) induces stenotic-kidney dysfunction and injury, but whether these arise from cellular senescenceand their temporal pattern remain unknown.
Methods
Chronic renal ischemia was induced in transgenic INK-ATTAC and wild type C57BL/6 mice by unilateral RAS, and kidney function (in vivo micro-MRI) and tissue damage were assessed. Mouse healthy and stenotic kidneys were analyzed using unbiased single-cell RNA-sequencing. To demonstrate translational relevance, cellular senescence was studied in human stenotic kidneys.
Results
Using intraperitoneal AP20187 injections starting 1, 2, or 4 weeks after RAS, selective clearance of cells highly expressing p16Ink4a attenuated cellular senescence and improved stenotic-kidney function; however, starting treatment immediately after RAS induction was unsuccessful. Broader clearance of senescent cells, using the oral senolytic combination dasatinib and quercetin, in C57BL/6 RAS mice was more effective in clearing cells positive for p21 (Cdkn1a) and alleviating renal dysfunction and damage. Unbiased, single-cell RNA sequencing in freshly dissociated cells from healthy and stenotic mouse kidneys identified stenotic-kidney epithelial cells undergoing both mesenchymal transition and senescence. As in mice, injured human stenotic kidneys exhibited cellular senescence, suggesting this process is conserved.
Conclusions
Maladaptive tubular cell senescence, involving upregulated p16 (Cdkn2a), p19 (Cdkn2d), and p21 (Cdkn1a) expression, is associated with renal dysfunction and injury in chronic ischemia. These findings support development of senolytic strategies to delay chronic ischemic renal injury.Other authorsSee publication -
Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney
Scientific Reports
Kidney-resident macrophages promote angiogenesis and prevent fibrosis in ischemic kidneys.
Renal artery stenosis (RAS) caused by narrowing of arteries is characterized by microvascular damage. Macrophages are implicated in repair and injury, but the specific populations responsible for these divergent roles have not been identified. Here, we characterized murine kidney F4/80+CD64+ macrophages in three transcriptionally unique populations. Using fate-mapping and parabiosis studies, we…Kidney-resident macrophages promote angiogenesis and prevent fibrosis in ischemic kidneys.
Renal artery stenosis (RAS) caused by narrowing of arteries is characterized by microvascular damage. Macrophages are implicated in repair and injury, but the specific populations responsible for these divergent roles have not been identified. Here, we characterized murine kidney F4/80+CD64+ macrophages in three transcriptionally unique populations. Using fate-mapping and parabiosis studies, we demonstrate that CD11b/cint are long-lived kidney-resident (KRM) while CD11chiMϕ, CD11cloMϕ are monocyte-derived macrophages. In a murine model of RAS, KRM self-renewed, while CD11chiMϕ and CD11cloMϕ increased significantly, which was associated with loss of peritubular capillaries. Replacing the native KRM with monocyte-derived KRM using liposomal clodronate and bone marrow transplantation followed by RAS, amplified loss of peritubular capillaries. To further elucidate the nature of interactions between KRM and peritubular endothelial cells, we performed RNA-sequencing on flow-sorted macrophages from Sham and RAS kidneys. KRM showed a prominent activation pattern in RAS with significant enrichment in reparative pathways, like angiogenesis and wound healing. In culture, KRM increased proliferation of renal peritubular endothelial cells implying direct pro-angiogenic properties. Human homologs of KRM identified as CD11bintCD11cintCD68+ increased in post-stenotic kidney biopsies from RAS patients compared to healthy human kidneys, and inversely correlated to kidney function. Thus, KRM may play protective roles in stenotic kidney injury through expansion and upregulation of pro-angiogenic pathways.Other authorsSee publication -
Location, location, location: Beneficial effects of autologous fat transplantation
Scientifc Reports
Visceral adiposity is a risk factor for cardiovascular disorders, type 2 diabetes mellitus (T2D) and associated metabolic diseases. Sub-cutaneous fat is believed to be intrinsically different from visceral fat. To understand molecular mechanisms involved in metabolic advantages of fat transplantation, we studied a rat model of diet-induced adiposity. Adipokine genes (Adiponectin, Leptin, Resistin and Visfatin) were expressed at 10,000 to a million-fold lower in visceral fat depot as compared to…
Visceral adiposity is a risk factor for cardiovascular disorders, type 2 diabetes mellitus (T2D) and associated metabolic diseases. Sub-cutaneous fat is believed to be intrinsically different from visceral fat. To understand molecular mechanisms involved in metabolic advantages of fat transplantation, we studied a rat model of diet-induced adiposity. Adipokine genes (Adiponectin, Leptin, Resistin and Visfatin) were expressed at 10,000 to a million-fold lower in visceral fat depot as compared to peripheral (thigh/chest) fat depots. Interestingly, autologous transplantation of visceral fat to subcutaneous sites resulted in increased gene transcript abundance in the grafts by 3 weeks post-transplantation, indicating the impact of local (residence) factors influencing epigenetic memory. We show here that active transcriptional state of adipokine genes is linked with glucose mediated recruitment of enzymes that regulate histone methylation. Adipose depots have âresidence memoryâ and autologous transplantation of visceral fat to sub-cutaneous sites offers metabolic advantage
-
Cassia auriculata: Aspects of Safety Pharmacology and Drug Interaction
Evidence-based Compl. and Alt. Medicine
First study that proposes herb-drug interaction as part of safety pharmacology in herbal drug research
Patents
-
HERBAL EXTRACTS AND COMPOSITIONS PREPARED THEREFROM
Filed IN WO2012140666A2
-
HERBAL EXTRACTS AND COMPOSITIONS PREPARED THEREFROM
Filed IN 1208/MUM/2011
The present invention provides processes for the preparation of extracts of Cassia auriculata (CA) and compositions comprising an extract of the same. The present invention also provides pharmaceutically active compounds isolated from Cassia auriculata which are useful for the treatment of disorders which include diseases arising because of insulin resistance such as Type 2 Diabetes, obesity, cardiovascular diseases and associated increase in homocysteine.
Other inventorsSee patent
Courses
-
Excyte Mastery Class
-
Projects
-
M. Pharm Dissertation worked on “Effect of Pioglitazone, Metformin and Cassia auriculata extract on Gene Expression in Insulin resistant rat.“ SCOE, Pune, India. (Research Guide- Prof. Dr. Kalpana Joshi)
-
During M. Pharm dissertation work, I was introduced to molecular pharmacology and type 2 diabetes animal studies. During this period, I have sharpen mine molecular biology skills. This work actually help me to study molecular mechanistic pathways in particular tissues to evaluate the effect of herbal drug at molecular level.
During project I had assisted senior PhD student working on effect of Cassia auriculata in type 2 diabetes mellitus. I was actively involved in gene expression studies,…During M. Pharm dissertation work, I was introduced to molecular pharmacology and type 2 diabetes animal studies. During this period, I have sharpen mine molecular biology skills. This work actually help me to study molecular mechanistic pathways in particular tissues to evaluate the effect of herbal drug at molecular level.
During project I had assisted senior PhD student working on effect of Cassia auriculata in type 2 diabetes mellitus. I was actively involved in gene expression studies, in vivo studies, isolation of phytochemicals from plant extract using different chromatographic techniques including HPLC, TLC and flash chromatography and platelet aggregation studies.
Other creators
Languages
-
Gujarati
Elementary proficiency
-
Marathi
Full professional proficiency
-
English
Professional working proficiency
-
Hindi
Professional working proficiency
Recommendations received
4 people have recommended Amrutesh
Join now to viewMore activity by Amrutesh
-
#Cancer | #Immunotherapy | Time to Target the #Complement System 🤔 | "One Size Does NOT Fit All" | Insightful OPEN ACCESS #Review Now Breaking…
#Cancer | #Immunotherapy | Time to Target the #Complement System 🤔 | "One Size Does NOT Fit All" | Insightful OPEN ACCESS #Review Now Breaking…
Liked by Amrutesh Puranik, Ph.D.
-
☠️ ☠️ Profiling Natural Born Killers - Episode 2: An analysis of NK cell transcriptomes across healthy tissues https://lnkd.in/exW4CW24
☠️ ☠️ Profiling Natural Born Killers - Episode 2: An analysis of NK cell transcriptomes across healthy tissues https://lnkd.in/exW4CW24
Liked by Amrutesh Puranik, Ph.D.
-
We are thrilled to announce that after months of dedicated work, the launch date for our new website is finally here! Next week, we'll unveil a…
We are thrilled to announce that after months of dedicated work, the launch date for our new website is finally here! Next week, we'll unveil a…
Liked by Amrutesh Puranik, Ph.D.
-
#Immunotherapy on the Move in the #TumorMicroEnvironment | "Cellular Dynamics upon #ImmuneCheckpointInhibition" | Dvir Aran & Co. Dive Deep into…
#Immunotherapy on the Move in the #TumorMicroEnvironment | "Cellular Dynamics upon #ImmuneCheckpointInhibition" | Dvir Aran & Co. Dive Deep into…
Liked by Amrutesh Puranik, Ph.D.
-
Lymphocytes as a living drug for cancer: The FDA approval of lifileucel hallmarks the availability of the first cellular therapy for solid cancer…
Lymphocytes as a living drug for cancer: The FDA approval of lifileucel hallmarks the availability of the first cellular therapy for solid cancer…
Liked by Amrutesh Puranik, Ph.D.
-
Happy Flow Friday! Dive into this publication recently featured in “Cytometry Part A” which describes the development and optimization of a…
Happy Flow Friday! Dive into this publication recently featured in “Cytometry Part A” which describes the development and optimization of a…
Liked by Amrutesh Puranik, Ph.D.
-
We are pleased to welcome to our Faculty Dr Ankur Sharma, who brings with him a leading expertise in cancer biology and an existing program of…
We are pleased to welcome to our Faculty Dr Ankur Sharma, who brings with him a leading expertise in cancer biology and an existing program of…
Liked by Amrutesh Puranik, Ph.D.
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More